Total number of patients | 56 |
Sex | |
Male | 42 (75) |
Female | 14 (25) |
Age yrs | |
Mean±sd | 65.5±9.3 |
Median (IQR) | 66 (57–73) |
Steroid treatment | |
At admission | 43 |
Systemic use | 40 |
Inhaled only | 3 |
In hospital (systemic use) | 49 |
None | 2 |
NA | 5 |
Clinical signs (total patients available) | |
Antibiotic resistant pneumonia | 53 (56) |
Dyspnoea exacerbation | 48 (48) |
Wheezing increase | 22 (28) |
Fever >38°C | 15 (39) |
Haemoptysis | 5 (12) |
Parietal pain | 4 |
Tracheobronchitis during bronchoscopy | 6 (33) |
Duration between symptoms and diagnosis days | |
Mean±sd | 12.5±11.3 |
Median (IQR) | 8.5 (6–16.5) |
Ventilation | |
Invasive | 43 |
Noninvasive ventilation | 1 |
None | 10 |
NA | 2 |
Total leukocytes | |
<12000 | 10 |
>12000 | 30 |
NA | 16 |
Outcome¶ | |
Death | 53 (95) |
Survival | 3 (5) |